Page 147 - Read Online

Page 12 of 13 Bale et al. Hepatoma Res 2023;9:44 https://dx.doi.org/10.20517/2394-5079.2023.71

intrahepatic cholangiocarcinoma. Br J Radiol 2022;95:20211379. DOI
46. Ni JY, An C, Zhang TQ, Huang ZM, Jiang XY, Huang JH. Predictive value of the albumin-bilirubin grade on long-term outcomes of
CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperthermia 2019;36:328-36. DOI PubMed
47. Yang H, Cheng Z, Han Z, et al. Assessment of the outcomes of intrahepatic cholangiocarcinoma after ultrasound-guided percutaneous
microwave ablation based on albumin-bilirubin grade. Cardiovasc Inter Rad 2021;44:261-70. DOI PubMed
48. Zhang K, Yu J, Yu X, et al. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma.
Int J Hyperthermia 2018;34:292-7. DOI
49. Giorgio A, Gatti P, Montesarchio L, et al. Intrahepatic cholangiocarcinoma and thermal ablation: long-term results of an italian
retrospective multicenter study. J Clin Transl Hepatol 2019;7:287-92. DOI PubMed PMC
50. Zhang SJ, Hu P, Wang N, et al. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann
Surg Oncol 2013;20:3596-602. DOI
51. Xu C, Li L, Xu W, et al. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic
cholangiocarcinoma: intermediate-term results. Int J Hyperthermia 2019;36:350-7. DOI
52. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-
analysis and review of contributing factors. Ann Surg 2005;242:158-71. DOI PubMed PMC
53. Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for
local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol 2020;30:2463-72. DOI
PubMed PMC
54. Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of
ablation experts, the interventional oncology Sans Frontières meeting 2013. Eur Radiol 2015;25:3438-54. DOI PubMed PMC
55. Lucatelli P, Argirò R, Crocetti L, et al. Percutaneous thermal segmentectomy: proof of concept. Cardiovasc Intervent Radiol
2022;45:665-76. DOI
56. Bale R, Widmann G, Stoffner DI. Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol
2010;75:32-6. DOI PubMed
57. Ortler M, Unterhofer C, Bauer R, Dobesberger J, Trinka E, Bale R. Flexibility of head positioning and head fixation provided by a
novel system for non-invasive maxillary fixation and frameless stereotaxy: technical note. Minim Invasive Neurosurg 2009;52:144-8.
DOI PubMed
58. Freysinger W, Gunkel AR, Bale R, et al. Three-dimensional navigation in otorhinolaryngological surgery with the viewing wand. Ann
Otol Rhinol Laryngol 1998;107:953-8. DOI
59. Bale R, Widmann G. Navigated CT-guided interventions. Minim Invasive Ther Allied Technol 2007;16:196-204. DOI PubMed
60. Bale R, Widmann G, Jaschke W. Stereotaxy and robotics for ablation - toy or tool? Radiologe 2012;52:56-62. DOI PubMed
61. Kettenbach J, Kara L, Toporek G, Fuerst M, Kronreif G. A robotic needle-positioning and guidance system for CT-guided puncture: ex
vivo results. Minim Invasive Ther Allied Technol 2014;23:271-8. DOI PubMed
62. Schaible J, Pregler B, Verloh N, et al. Improvement of the primary efficacy of microwave ablation of malignant liver tumors by using a
robotic navigation system. Radiol Oncol 2020;54:295-300. DOI PubMed PMC
63. Scharll Y, Letrari S, Laimer G, Schullian P, Bale R. Puncture accuracy of an optical tracked robotic aiming device-a phantom study.
Eur Radiol 2022;32:6769-76. DOI PubMed PMC
64. Kim-Fuchs C, Candinas D, Lachenmayer A. The role of conventional and stereotactic microwave ablation for intrahepatic
cholangiocarcinoma. J Clin Med 2021;10:2963. DOI PubMed PMC
65. Schullian P, Putzer D, Eberle G, Laimer G, Bale R. Simultaneous Stereotactic radiofrequency ablation of multiple (≥ 4) liver tumors:
feasibility, safety, and efficacy. J Vasc Interv Radiol 2020;31:943-52. DOI PubMed
66. Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Inter Rad 2011;34:852-6. DOI PubMed
67. Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R. Safety and efficacy of stereotactic radiofrequency ablation for very
large (≥8 cm) primary and metastatic liver tumors. Sci Rep 2020;10:1618. DOI PubMed PMC
68. Schullian P, Johnston E, Laimer G, et al. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence. HPB
2022;24:1044-54. DOI
69. Schullian P, Laimer G, Putzer D, et al. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic
resection. Eur J Surg Oncol 2020;46:1503-9. DOI
70. Bale R, Schullian P, Eberle G, et al. Stereotactic radiofrequency ablation of hepatocellular carcinoma: a histopathological study in
explanted livers. Hepatology 2019;70:840-50. DOI PubMed PMC
71. Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R. Stereotactic radiofrequency ablation of subcardiac hepatocellular
carcinoma: a case-control study. Int J Hyperthermia 2019;36:876-85. DOI PubMed
72. Bale R, Widmann G, Schullian P, et al. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol
2012;22:930-7. DOI
73. Schullian P, Johnston E, Laimer G, et al. Stereotactic radiofrequency ablation of breast cancer liver metastases: short- and long-term
results with predicting factors for survival. Cardiovasc Intervent Radiol 2021;44:1184-93. DOI PubMed PMC
74. Putzer D, Schullian P, Bale R. Locoregional ablative treatment of melanoma metastases. Int J Hyperthermia 2019;36:59-63. DOI
PubMed
75. Schullian P, Johnston EW, Putzer D, et al. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after